Skip to main content
Veterinary Medicines

Insol Trichophyton suspension for injection

Authorised
  • Trichophyton mentagrophytes, strain 551, Inactivated
  • Trichophyton mentagrophytes, strain 1032, Inactivated
  • Trichophyton verrucosum, strain 410, Inactivated

Product identification

Medicine name:
Insol Trichophyton suspension for injection
Insol Trichophyton
Active substance:
  • Trichophyton mentagrophytes, strain 551, Inactivated
  • Trichophyton mentagrophytes, strain 1032, Inactivated
  • Trichophyton verrucosum, strain 410, Inactivated
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Trichophyton mentagrophytes, strain 551, Inactivated
  • Trichophyton mentagrophytes, strain 1032, Inactivated
  • Trichophyton verrucosum, strain 410, Inactivated
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        3
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AQ
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • (ID3): 1 Box with 1 Bottle (Glass) with 250 millilitre(s) (250 millilitre(s))
  • (ID1): 1 Box with 1 Bottle (Glass) with 50 millilitre(s) (50 millilitre(s))
  • (ID2): 1 Box with 1 Bottle (Glass) with 100 millilitre(s) (100 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Vetmedica GmbH
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 277a/94
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0201/001
Concerned member states:
  • Sweden

Documents

Summary of Product Characteristics

English (PDF)
Published on: 10/02/2022
Download
German (PDF)
Published on: 10/02/2022